“It all started when I was 58. I didn’t have any symptoms – apart from needing to go to the toilet a lot. At night, I was trying to pee, couldn’t, then went back to bed and the next minute needed to ...

Dr Anna Wilkins’ group is investigating how to target the tumour microenvironment of bladder and prostate cancer to prevent treatment resistance, especially to radiation given with curative intent.

Andrew joined the ICR initially as a post-doctoral scientist before moving to industry to work as a senior medicinal chemist. He re-joined ICR in March 2021 as a Medicinal Chemist in the Centre for ...

A new study has shown that small genetic changes in a key protein can determine whether myeloma cells resist or respond to treatment – findings that could help clinicians choose more effective ...